As of 2025-07-04, the Fair Value of Corbus Pharmaceuticals Holdings Inc (CRBP) is -20.64 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.71 USD, the upside of Corbus Pharmaceuticals Holdings Inc is -367.72%.
With the market price of 7.71 USD and our fair value calculation, Corbus Pharmaceuticals Holdings Inc (CRBP) is not a good investment. Investing in CRBP stocks now will result in a potential loss of 367.72%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -111.27 | -45.64 | -42.35 | -45.00 | -40.00 | -56.85 |
| YoY growth | -55.73% | 58.98% | 7.21% | -6.26% | 11.11% | 3.06% |
| Market Cap (mil) | 94.37 |
| P/E | |
| Forward P/E |
| EPS | -4.13 |
| Avg earnings growth rate | 3.06% |
| TTM earnings | -50.53 |